DYNEX CAPITAL INC (DX)

US26817Q8868 - REIT

12.16  -0.06 (-0.49%)

After market: 12.1496 -0.01 (-0.09%)

Fundamental Rating

2

Overall DX gets a fundamental rating of 2 out of 10. We evaluated DX against 64 industry peers in the Mortgage Real Estate Investment Trusts (REITs)" industry. DX has a bad profitability rating. Also its financial health evaluation is rather negative. DX is valied quite expensively at the moment, while it does show a decent growth rate.



2

1. Profitability

1.1 Basic Checks

In the past year DX has reported negative net income.
DX had a positive operating cash flow in the past year.
In multiple years DX reported negative net income over the last 5 years.
DX had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

Looking at the Return On Assets, with a value of 0.09%, DX is doing worse than 60.94% of the companies in the same industry.
Looking at the Return On Equity, with a value of 0.64%, DX is in line with its industry, outperforming 40.63% of the companies in the same industry.
Industry RankSector Rank
ROA 0.09%
ROE 0.64%
ROIC N/A
ROA(3y)2.01%
ROA(5y)1.63%
ROE(3y)8.41%
ROE(5y)4.42%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

DX's Profit Margin of 5.58% is in line compared to the rest of the industry. DX outperforms 46.88% of its industry peers.
DX does not have Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) 5.58%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A

0

2. Health

2.1 Basic Checks

DX does not have a ROIC to compare to the WACC, probably because it is not profitable.
DX has more shares outstanding than it did 1 year ago.
DX has more shares outstanding than it did 5 years ago.
DX has a worse debt/assets ratio than last year.

2.2 Solvency

DX has an Altman-Z score of -1.02. This is a bad value and indicates that DX is not financially healthy and even has some risk of bankruptcy.
The Altman-Z score of DX (-1.02) is worse than 89.06% of its industry peers.
The Debt to FCF ratio of DX is 66.08, which is on the high side as it means it would take DX, 66.08 years of fcf income to pay off all of its debts.
With a Debt to FCF ratio value of 66.08, DX is not doing good in the industry: 64.06% of the companies in the same industry are doing better.
DX has a Debt/Equity ratio of 6.22. This is a high value indicating a heavy dependency on external financing.
DX's Debt to Equity ratio of 6.22 is on the low side compared to the rest of the industry. DX is outperformed by 70.31% of its industry peers.
Industry RankSector Rank
Debt/Equity 6.22
Debt/FCF 66.08
Altman-Z -1.02
ROIC/WACCN/A
WACC3.47%

2.3 Liquidity

A Current Ratio of 0.06 indicates that DX may have some problems paying its short term obligations.
With a Current ratio value of 0.06, DX is not doing good in the industry: 76.56% of the companies in the same industry are doing better.
A Quick Ratio of 0.06 indicates that DX may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.06, DX is doing worse than 76.56% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.06
Quick Ratio 0.06

6

3. Growth

3.1 Past

The earnings per share for DX have decreased strongly by -144.44% in the last year.
The Revenue has grown by 26.19% in the past year. This is a very strong growth!
Measured over the past years, DX shows a small growth in Revenue. The Revenue has been growing by 3.79% on average per year.
EPS 1Y (TTM)-144.44%
EPS 3YN/A
EPS 5YN/A
EPS growth Q2Q-216.67%
Revenue 1Y (TTM)26.19%
Revenue growth 3Y11.17%
Revenue growth 5Y3.79%
Revenue growth Q2Q210.09%

3.2 Future

Based on estimates for the next years, DX will show a very strong growth in Earnings Per Share. The EPS will grow by 59.44% on average per year.
Based on estimates for the next years, DX will show a very strong growth in Revenue. The Revenue will grow by 82.32% on average per year.
EPS Next Y58.53%
EPS Next 2Y59.44%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year61.56%
Revenue Next 2Y82.32%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

1

4. Valuation

4.1 Price/Earnings Ratio

DX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year DX is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Price/Free Cash Flow ratio of DX is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 9.16
EV/EBITDA N/A

4.3 Compensation for Growth

DX's earnings are expected to grow with 59.44% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y59.44%
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

DX has a Yearly Dividend Yield of 12.75%, which is a nice return.
DX's Dividend Yield is a higher than the industry average which is at 12.60.
DX's Dividend Yield is rather good when compared to the S&P500 average which is at 2.45.
Industry RankSector Rank
Dividend Yield 12.75%

5.2 History

The dividend of DX decreases each year by -10.00%.
DX has been paying a dividend for at least 10 years, so it has a reliable track record.
DX has decreased its dividend recently.
Dividend Growth(5Y)-10%
Div Incr Years0
Div Non Decr Years1

5.3 Sustainability

1731.65% of the earnings are spent on dividend by DX. This is not a sustainable payout ratio.
DP1731.65%
EPS Next 2Y59.44%
EPS Next 3YN/A

DYNEX CAPITAL INC

NYSE:DX (2/26/2024, 7:04:00 PM)

After market: 12.1496 -0.01 (-0.09%)

12.16

-0.06 (-0.49%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupFinancial Services
GICS IndustryMortgage Real Estate Investment Trusts (REITs)"
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap693.61M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 12.75%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.09%
ROE 0.64%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) 5.58%
GM N/A
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.02
Health
Industry RankSector Rank
Debt/Equity 6.22
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 0.06
Quick Ratio 0.06
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-144.44%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y58.53%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)26.19%
Revenue growth 3Y11.17%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y